Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Megha Udupa

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 19, 2026
Piloleiomyoma and renal cell carcinoma in a 30-year-old woman with hereditary leiomyomatosis and renal cell cancer syndromeMegha Udupa, William D Foulkes, Fadi Brimo, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 30, 2026
Megha Udupa, William D Foulkes, Fadi Brimo, et al.
Journal of Cutaneous Medicine and Surgery|September 11, 2025
Patient-Centered Outcomes in Non-Melanoma Skin Cancer Management: A Comprehensive ReviewMegha Udupa, David Roberge, Han Zhang Huang, et al.
Journal of the American Academy of Dermatology|June 1, 2025
Clinical presentations and outcomes of cutaneous metastases from prostate cancer: A systematic reviewMegha Udupa, Shu Yu Qian, Shreya Udupa, et al.
Journal of Cutaneous Medicine and Surgery|April 30, 2025
The Efficacy of Off-Label Abrocitinib in Alopecia Areata: A Systematic ReviewBianca Te, Megha Udupa, Jeffrey Toy, et al.
Journal of Cutaneous Medicine and Surgery|February 15, 2025
The Efficacy of Off-Label Dupilumab in Cutaneous AmyloidosisBianca Te, Megha Udupa, Jeffrey Toy, et al.
Indian Journal of Dermatology, Venereology and Leprology|February 8, 2026
Dupilumab in lichen planus, and dupilumab-induced lichenoid drug eruption: A systematic reviewBianca Te, Megha Udupa, Jeffrey Toy, et al.
Journal of the American Academy of Dermatology|September 29, 2025
The efficacy and tolerability of off-label dupilumab in acantholytic dyskeratotic disordersMegha Udupa, Bianca Te, Valerie C Doyon, et al.
Journal of the American Academy of Dermatology|June 18, 2025
Tattoo inks and carcinogenic risk: Current evidence and regulatory gapsAlexandra Peebles, Lea Saroufim, Megha Udupa, et al.
SAGE Open Medical Case Reports|June 23, 2025
Treatment of Hailey-Hailey disease with the Janus kinase inhibitor abrocitinib: A case reportMolly Gunyon, Megha Udupa, Farhan Mahmood, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 19, 2026
Piloleiomyoma and renal cell carcinoma in a 30-year-old woman with hereditary leiomyomatosis and renal cell cancer syndromeMegha Udupa, William D Foulkes, Fadi Brimo, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 30, 2026
Megha Udupa, William D Foulkes, Fadi Brimo, et al.
Journal of Cutaneous Medicine and Surgery|September 11, 2025
Patient-Centered Outcomes in Non-Melanoma Skin Cancer Management: A Comprehensive ReviewMegha Udupa, David Roberge, Han Zhang Huang, et al.
Journal of the American Academy of Dermatology|June 1, 2025
Clinical presentations and outcomes of cutaneous metastases from prostate cancer: A systematic reviewMegha Udupa, Shu Yu Qian, Shreya Udupa, et al.
Journal of Cutaneous Medicine and Surgery|April 30, 2025
The Efficacy of Off-Label Abrocitinib in Alopecia Areata: A Systematic ReviewBianca Te, Megha Udupa, Jeffrey Toy, et al.
Journal of Cutaneous Medicine and Surgery|February 15, 2025
The Efficacy of Off-Label Dupilumab in Cutaneous AmyloidosisBianca Te, Megha Udupa, Jeffrey Toy, et al.
Indian Journal of Dermatology, Venereology and Leprology|February 8, 2026
Dupilumab in lichen planus, and dupilumab-induced lichenoid drug eruption: A systematic reviewBianca Te, Megha Udupa, Jeffrey Toy, et al.
Journal of the American Academy of Dermatology|September 29, 2025
The efficacy and tolerability of off-label dupilumab in acantholytic dyskeratotic disordersMegha Udupa, Bianca Te, Valerie C Doyon, et al.
Journal of the American Academy of Dermatology|June 18, 2025
Tattoo inks and carcinogenic risk: Current evidence and regulatory gapsAlexandra Peebles, Lea Saroufim, Megha Udupa, et al.
SAGE Open Medical Case Reports|June 23, 2025
Treatment of Hailey-Hailey disease with the Janus kinase inhibitor abrocitinib: A case reportMolly Gunyon, Megha Udupa, Farhan Mahmood, et al.
Pageof 2